Endexx (EDXC) Stock Price, News & Analysis
Company Description
Endexx (OTC Link: EDXC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.1M.
EDXC has declined 97.5% over the past year. Shares last traded at $0.0001.
For FY2022, Endexx reported revenue of $2.1M with net income of -$4.9M. The company operates at a net profit margin of -228.5%.
This page collects what Stock Titan holds for EDXC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Endexx (EDXC) stock last closed at $0.0001. Over the past 12 months, the stock has lost 97.5%. At a market capitalization of $2.1M, EDXC is classified as a micro-cap stock with approximately 571.9M shares outstanding.
EDXC Rankings
Latest News
Endexx has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, management, earnings. View all EDXC news →
SEC Filings
Financial Highlights
Endexx generated $2.1M in revenue in FY2022, retaining a 55.8% gross margin, operating income reached -$3.9M (-183.2% operating margin), and net income was -$4.9M, reflecting a -228.5% net profit margin. The company generated -$2.1M in operating cash flow. With a current ratio of 0.18, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Endexx (EDXC) currently stands at 226 shares, down 96.2% from the previous reporting period. Since July 2025, short interest has decreased by 99.7%.
Days to Cover History
Days to cover for Endexx (EDXC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
EDXC Company Profile & Sector Positioning
Endexx (EDXC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EDXC often look at related companies in the same sector, including STEMTECH CORPORATION (STEK), Cannapharmarx (CPMD), Tilt Hldgs Inc (TLLTF), Nxgen Brands (NXGB), and Aion Therapeutic (ANTCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EDXC's relative position within its industry.